Clinical Trial Update: Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates [NA]

View source ↗

Summary

A completed clinical trial evaluated the impact of macrocomposition on nonalcoholic fatty liver disease in bariatric surgery candidates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: University of Michigan | Conditions: Morbid Obesity, Non-alcoholic Fatty Liver Disease | NA | Status: COMPLETED